Article
Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society - 1 Oct 2020
Voutsadakis Ioannis A
Abstract excerpt
Low-grade serous ovarian carcinoma and its high-grade serous ovarian carcinoma counterpart differ in their precursor lesions, molecular profile, natural history, and response to therapies. As such, low-grade serous ovarian carcinoma needs to be studied separately from high-grade serous ovarian carcinoma, despite challenges stemming from its rarity. A deeper understanding of the pathogenesis of low-grade serous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
